GENVOYA is a quad pill approved in late 2015 that contains  elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide. It is now  one of the first line drug combinations recommended by the WHO.  It is taken once a day at the same time with food.  It is generally extremely well tolerated.